March 2020 FDA Recall Drug by Jubilant Cadista Pharmaceuticals, Inc.
D-1058-2020 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Jubilant Cadista Pharmaceuticals, Inc. on March 11, 2020 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1058-2020

Reason for Recall
CGMP Deviations: Presence of dark brown discoloration on edges of tablets
Initiated
03-11-2020
Reported
03-25-2020
Quantity
89,376 90-count bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Jubilant Cadista Pharmaceuticals, Inc.
Distributed Nationwide in the USA
Pantoprazole Sodium Delayed-Release Tablets, USP, 40 mg, 90 count bottle, Rx Only, Manufactured by Jubilant Generics Ltd, Roorkee-247661 India, NDC 59746-284-90

Batch or Lot Expiration Information

Lot# PA218005A, exp. date 12/2020, PA218P010, PA218P011, exp. date 04/2021, PA218108A, PA218110A, exp. date 06/2021